Search
for
Sort by
Research 331–360 of 1000+
- Eflúvio Telógeno após a infecção por COVID 19: uma revisão narrativa sobre o mecanismo fisiológico / Telogen Effluvium after SARS-CoV-2 infection: a narrative review of physiological mechanism
- Alopecia androgênica como agravo da infecção por SARS-CoV-2
- Excessive hair loss as a complication after infection with SARS-CoV-2 virus
- SARS-CoV-2 infection reduces the number of spermatogonial stem cells and dysregulates the transcriptional landscape of the human testis
- SARS‐CoV‐2 & androgenic alopecia: exploring links!
- Studying SARS-CoV-2 infectivity and therapeutic responses with complex organoids
- Identifying SARS-CoV-2 entry inhibitors through drug repurposing screens of SARS-S and MERS-S pseudotyped particles
- 5-Alpha-Reductase Inhibitors Reduce Remission Time of COVID-19: Results From a Randomized Double Blind Placebo Controlled Interventional Trial in 130 SARS-CoV-2 Positive Men
- Anti-SARS-CoV-2 Action of 5α-Reductase Inhibitors May Be Mediated by Dehydroepiandrosterone. Letter.
- Immunoreactivity of the SARS-CoV-2 entry proteins ACE-2 and TMPRSS-2 in murine models of hormonal manipulation, ageing, and cardiac injury
- Study of SARS-CoV-2 in semen and urine samples of a volunteer with positive naso-pharyngeal swab
- Comparison of viral RNA–host protein interactomes across pathogenic RNA viruses informs rapid antiviral drug discovery for SARS-CoV-2
- Inhibition of SARS-CoV-2 entry through the ACE2/TMPRSS2 pathway: a promising approach for uncovering early COVID-19 drug therapies
- Structural insights into SARS-CoV-2 spike protein and its natural mutants found in Mexican population
- Role of testosterone in SARS-CoV-2 infection: A key pathogenic factor and a biomarker for severe pneumonia
- Spiking dependence of SARS‐CoV‐2 pathogenicity on TMPRSS2
- Candidate genes of SARS-CoV-2 gender susceptibility
- Factors associated with anti-SARS-CoV-2 IgG antibody production in patients convalescing from COVID-19
- Basic mechanisms of SARS-CoV-2 infection. What endocrine systems could be implicated?
- Clomipramine suppresses ACE2-mediated SARS-CoV-2 entry
- Androgens in SARS-CoV-2 Coronavirus Infections
- Telogen effluvium in SARS‐CoV‐2 infection: Histological aspects
- From bedside to bench: regulation of host factors in SARS-CoV-2 infection
- Evaluation of SARS-CoV-2 Entry, Inflammation and New Therapeutics in Human Lung Tissue Cells
- Evaluation of SARS-CoV-2 entry, inflammation and new therapeutics in human lung tissue cells
- NOVEL CORONAVIRUS (SARS-COV-2): MOLECULAR BIOLOGY, PATHOGENESIS, PATHOBIOLOGY AND ADVANCES IN TREATMENT OF COVID-19 PATIENTS– AN UPDATE
- Severe Acute SARS-CoV-2 Infection and Long COVID: What Do We Know So Far? New Challenges in Diagnosis and Management
- Hair loss after SARS-CoV2 Infection
- Network-based identification genetic effect of SARS-CoV-2 infections to Idiopathic pulmonary fibrosis (IPF) patients
- Medical education and care in dermatology during the SARS‐CoV2 pandemia: challenges and chances